Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT04759248

Active, not recruiting

Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer (ATREZZO)

Breast Cancer
NCT06873802

Completed

ZTE MRI Pulse Sequence Use for Visualization of Bone Cement, Breast Biopsy Markers

Breast Carcinoma
NCT06151639

Completed

Comparison of The Effects Of General Anesthesia and PECS Block Methods on Blood Counts in Patients With Breast Cancer

Breast Cancer
NCT05942105

Active, not recruiting

Different Localization Techniques for Non-palpable Breast Lesions Comparison: a Retrospective and Multicentric Clinical Study (Localization01)

Breast Cancer
NCT03417115

Active, not recruiting

Breast Cancer Registry Platform (OPAL)

Breast Cancer
NCT02910986

Completed

Behavioral and Psychological Impact of Returning Breast Density Results to Latinas

Breast Cancer
NCT07108595

Completed

Efficacy and Safety of T-DXd in Patients With HER2-positive and HER2-low Metastatic Breast Cancer: a Real-world Study

Breast Cancer
NCT04256512

Completed

Cryotherapy for the Prevention of Taxane-Induced Sensory Neuropathy of the Hands and Feet in Breast Cancer Patients

Breast Carcinoma
NCT06224244

Active, not recruiting

External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients (ESIBIRE)

Breast Cancer | Breast Neoplasms
NCT07069803

Completed

Oncologic Outcomes of Minimal Access Nipple-sparing Mastectomy Compared With Conventional Approach in Breast Cancer

Breast Cancer
NCT00941759

Completed

Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer

Breast Cancer
NCT02436993

Active, not recruiting

Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab

Breast Carcinoma
NCT01943695

Active, not recruiting

Supervised Aerobic Training During or After Chemotherapy for Operable Breast Cancer

Breast Cancer
NCT02955394

Active, not recruiting

Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer

Breast Cancer
NCT03816839

Terminated

Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2) (AMEERA-2)

Breast Cancer
NCT01937117

Active, not recruiting

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Breast Cancer
NCT05520515

Active, not recruiting

Water and Land-based Aerobic Training in Breast Cancer Survivors (WaterMama)

Breast Cancer
NCT06394661

Active, not recruiting

Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer

Breast Cancer
NCT01354522

Completed

TAC Versus TCX as Adjuvant Treatment for High-risk Her2-Negative Breast Cancer

Breast Cancer
NCT03304587

Completed

Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors

Breast Cancer
NCT03222856

Completed

Ph II Study of Pembrolizumab & Eribulin in Patients With HR+/HER2- MBC Previously Treated With Anthracyclines & Taxanes (KELLY)

Breast Cancer
NCT00393783

Active, not recruiting

Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity

Breast Cancer
NCT02546232

Active, not recruiting

Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic Setting

Breast Cancer
NCT06990347

Completed

A Study on the Efficacy and Safety of IPyC for HER2+ MBC

Breast Cancer
NCT06121453

Suspended

Adherence Intervention in Patients With Metastatic Breast Cancer

Breast Cancer
NCT00322894

Completed

Expanded Breast Cancer Registry and Tissue Repository

Breast Cancer
NCT05990478

Withdrawn

A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer

Breast Cancer
NCT05618613

Terminated

Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer (ELONA)

Breast Cancer
NCT02764541

Active, not recruiting

Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)

Breast Cancer
NCT02115607

Completed

Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy

Breast Cancer
NCT06190600

Active, not recruiting

Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy (SPORTNATHy)

Breast Cancer
NCT03170648

Completed

Ear Acupuncture During Chemotherapy Infusion for Breast Cancer, a Feasibility Study

Breast Cancer
NCT02827370

Completed

CAREFOR: Precision Medicine Driving Precision Nutrition for the Treatment of NeoAdjuvant Breast Cancer

Breast Carcinoma
NCT03054025

Terminated

Smart Phone Application in Increasing Physical Activity in Breast Cancer Survivors

Breast Cancer
NCT05073432

Completed

Development of a Personalized Discussion Prioritization Tool for Older Adults Considering Adjuvant Chemotherapy for Breast Cancer

Breast Cancer
NCT06938711

Withdrawn

A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer

Breast Cancer
NCT04125277

Active, not recruiting

The SONImage Study (SONImage)

Breast Cancer
NCT04098640

Enrolling by invitation

Molecular Profiling in Young (<50 Years of Age) Patients With Metastatic Breast Cancer

Breast Cancer
NCT01396655

Completed

PET in Breast Cancer Receiving Neoadjuvant Chemotherapy (DA-PET)

Breast Cancer
NCT05914792

Active, not recruiting

Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery

Breast Cancer
NCT01779206

Completed

ADAPT - Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer (ADAPT)

Breast Cancer
NCT06547034

Completed

VisR for Noninvasively Interrogating Stromal Collagen Organization as a Breast Cancer Biomarker: Evaluation of Compression in Control Subjects

Breast Cancer
NCT00490139

Completed

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D (ALTTO)

Neoplasms, Breast
NCT04142476

Terminated

Evaluation of the Impact of a Pharmaceutical Interview on the Adherence to Hormonotherapy in Women With Breast Cancer (HORMONOVILLE)

Breast Cancer
NCT04109066

Completed

Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer (CheckMate 7FL)

Breast Cancer
NCT05747794

Active, not recruiting

Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination with Paclitaxel Chemotherapy (AIPAC-003)

Breast Carcinoma
NCT06344780

Active, not recruiting

Abemaciclib, Palbociclib or Dalpiciclib Combined with Endocrine Therapy As First-line Treatment in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer

Breast Cancer
NCT01186367

Completed

Trial Comparing the Effects of Linear Versus Nonlinear Aerobic Training in Women With Operable Breast Cancer (Excite)

Breast Cancer
NCT06172270

Completed

Sub-regional Tumor Segmentation Based on CEUS Perfusion Characteristics: Enhancing Breast Tumor Diagnosis

Breast Tumor
NCT03944434

Active, not recruiting

FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer (FACILE)

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations